This site is intended for health professionals only

Published on 23 November 2011

Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
CHMP rejects UCB’s Cimzia for second time
Coronary stent systems: an update and a glance into the future
Experiences and insights
New prescription-only Fultium®-D3 Drops (colecalciferol) launched
Cell therapy trial for heart function

Understanding compassionate-use programmes

teaser

 

Prof Paola Minghetti, PhD  

Professor of Pharmaceutical Sciences, Universit



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Janssen-Cilag’s Stelara approved by NICE
4
Merck agrees huge Vioxx settlement
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Merck Serono to continue development of Tecemotide in Stage III non-small cell lung cancer
Shares soar after generic drug deal
Drug ‘does not cause heart attack’
Infection with COVID-19 variant of concern B.1.1.7 does not appear to lead to more severe disease
Europe recognises importance of rare diseases